Do Older Men Benefit From Curative Therapy of Localized Prostate Cancer?
- 1 September 2003
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 21 (17) , 3318-3327
Abstract
Purpose: Prior decision-analytic models are based on outdated or suboptimal efficacy, patient preference, and comorbidity data. We estimated life expectancy (LE) and quality-adjusted life expectancy (QALE) associated with available treatments for localized prostate cancer in men aged ≥ 65 years, adjusting for Gleason score, patient preferences, and comorbidity.Keywords
This publication has 75 references indexed in Scilit:
- Patient and Community Preferences for Outcomes in Prostate CancerMedical Care, 2003
- The Danger of Applying Group-level Utilities in Decision Analyses of the Treatment of Localized Prostate Cancer in Individual PatientsMedical Decision Making, 1998
- A gleason score of 7 predicts a worse outcome for prostate carcinoma patients treated with radiotherapyCancer, 1998
- The UCLA Prostate Cancer IndexMedical Care, 1998
- Decision Analysis for Treatment of Early Stage Prostate CancerJapanese Journal of Cancer Research, 1998
- Assessment of quality of life after radical radiotherapy for prostate cancerBritish Journal of Urology, 1996
- A Markov model of the natural history of prostate cancerJournal of Clinical Epidemiology, 1994
- How useful are models of natural history in clinical decision making and clinical research?Journal of Clinical Epidemiology, 1994
- Carcinoma of the prostate: Results of radical radiotherapy (1970–1985)International Journal of Radiation Oncology - Biology - Physics (IJROBP), 1993
- Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706International Journal of Radiation Oncology - Biology - Physics (IJROBP), 1991